These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9234533)

  • 1. The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs.
    McClements WL; Armstrong ME; Keys RD; Liu MA
    Vaccine; 1997 Jun; 15(8):857-60. PubMed ID: 9234533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
    Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T
    Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C.
    Mester JC; Twomey TA; Tepe ET; Bernstein DI
    Vaccine; 1999 Dec; 18(9-10):875-83. PubMed ID: 10580201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.
    McClements WL; Armstrong ME; Keys RD; Liu MA
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11414-20. PubMed ID: 8876149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
    J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Dalimi Asl A
    Iran Biomed J; 2008 Apr; 12(2):59-66. PubMed ID: 18506211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
    J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.
    Bourne N; Milligan GN; Schleiss MR; Bernstein DI; Stanberry LR
    Vaccine; 1996 Sep; 14(13):1230-4. PubMed ID: 8961510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA immunization against experimental genital herpes simplex virus infection.
    Bourne N; Stanberry LR; Bernstein DI; Lew D
    J Infect Dis; 1996 Apr; 173(4):800-7. PubMed ID: 8603957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
    Çuburu N; Wang K; Goodman KN; Pang YY; Thompson CD; Lowy DR; Cohen JI; Schiller JT
    J Virol; 2015 Jan; 89(1):83-96. PubMed ID: 25320297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.
    Veselenak RL; Shlapobersky M; Pyles RB; Wei Q; Sullivan SM; Bourne N
    Vaccine; 2012 Nov; 30(49):7046-51. PubMed ID: 23041125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.
    Domingo C; Gadea I; Pardeiro M; Castilla C; Fernández S; Fernández-Clua MA; De la Cruz Troca JJ; Punzón C; Soriano F; Fresno M; Tabarés E
    Vaccine; 2003 Sep; 21(25-26):3565-74. PubMed ID: 12922084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.
    Morello CS; Levinson MS; Kraynyak KA; Spector DH
    J Virol; 2011 Apr; 85(7):3461-72. PubMed ID: 21270160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immune correlates can segregate by vaccine type in a murine herpes model system.
    Sin JI; Ayyavoo V; Boyer J; Kim J; Ciccarelli RB; Weiner DB
    Int Immunol; 1999 Nov; 11(11):1763-73. PubMed ID: 10545480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.
    Shlapobersky M; Marshak JO; Dong L; Huang ML; Wei Q; Chu A; Rolland A; Sullivan S; Koelle DM
    J Gen Virol; 2012 Jun; 93(Pt 6):1305-1315. PubMed ID: 22398318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
    Fló J
    Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection.
    Bernstein DI
    Vaccine; 2000 Jan; 18(14):1351-8. PubMed ID: 10618532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.